Winton Group LTD Homology Medicines, Inc. Transaction History

Winton Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$8.92 - $13.29 $204,740 - $305,045	-22,953 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$9.94 - $16.59 $27,295 - $45,556	-2,746 Reduced 10.69%	22,953 $246,000
Q2 2020 Aug 05, 2020	BUY	$12.07 - $19.34 $81,677 - $130,873	6,767 Added 35.74%	25,699 $390,000
Q1 2020 May 11, 2020	SELL	$12.5 - $22.04 $204,787 - $361,081	-16,383 Reduced 46.39%	18,932 $294,000
Q4 2019 Feb 13, 2020	BUY	$11.42 - $22.19 $403,297 - $783,639	35,315 New	35,315 $731,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.